Drug Type Small molecule drug |
Synonyms Pegylated Glucagon Receptor Agonist, PB 722 |
Target |
Action agonists |
Mechanism GCGR agonists(Glucagon receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Hyperinsulinism | IND Approval | China | 08 May 2023 |